TOV-21G

Information for TOV-21G

Description

This cell line was initiated in October of 1991 from a patient of French-Canadian descent with no family history of ovarian cancer.

Source BRENDA Tissue Ontology (BTO)

ReMap Statistics

Datasets
2
Transcriptional Factors
1
Peaks
17,616
Non-redundant peaks
11,594

Description

Cell_name
TOV-21G
Category
Cancer cell line
Disease
NCIt; C40078; Ovarian clear cell adenocarcinoma
Sex_gender_of_cell
Female
Age_of_donor
62Y

External IDs

Cellosaurus
CVCL_3613
Experimental Factor
BRENDA Tissue
BTO:0005183
Wiki
TOV-21G
ATCC
TOV-21G
Synonyms
TOV-21g; TOV21; TOV21G
All peaks TOV-21G
Download BED file
Non redundant TOV-21G
Download BED file
CRMs TOV-21G
Download BED file
DOWNLOAD All ReMap
Go to catalogue

Datasets Table for TOV-21G

Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks
TOV-21G SMARCA4 GEO Homo sapiens GSE110448 Download (9306)
TOV-21G resistant SMARCA4 GEO Homo sapiens GSE110448 Download (8310)
Biotype Biotype modification Ecotype Target name Target modification Source Species Experiment Peaks